Literature DB >> 5559043

Testosterone therapy for anaemia in maintenance dialysis.

S Shaldon, K M Koch, F Oppermann, W D Patyna, W Schoeppe.   

Abstract

Intramuscular testosterone 250-500 mg weekly given to 25 patients on long-term haemodialysis produced a significant rise in haemoglobin level in all patients. The response was reversible when the drug was stopped. Treatment was effective in bilaterally nephrectomized patients and those with intact kidney tissue. The use of intramuscular testosterone is recommended for all adult patients on long-term haemodialysis in order to eliminate the need for routine blood transfusions.

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5559043      PMCID： PMC1798542          DOI： 10.1136/bmj.3.5768.212

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


  6 in total

1.  Testosterone-induced remission in aplastic anemia of both acquired and congenital types. Further observations in 24 cases.

Authors:  N T SHAHIDI; L K DIAMOND
Journal:  N Engl J Med       Date:  1961-05-11       Impact factor: 91.245

2.  Iron absorption in chronic renal disease.

Authors:  J W Eschbach; J D Cook; C A Finch
Journal:  Clin Sci       Date:  1970-02       Impact factor: 6.124

3.  Idiopathic aplastic anaemia in children. Results of androgen treatment.

Authors:  A Killander; K M Lundmark; S Sjölin
Journal:  Acta Paediatr Scand       Date:  1969-01

4.  Mechanism of testosterone action in erythropoiesis.

Authors:  E A Mirand; A S Gordon; J Wenig
Journal:  Nature       Date:  1965-04-17       Impact factor: 49.962

5.  Androgen actions on erythropoiesis.

Authors:  A S Gordon; E A Mirand; J Wenig; R Katz; E D Zanjani
Journal:  Ann N Y Acad Sci       Date:  1968-03-29       Impact factor: 5.691

6.  The erythropoietic-stimulating effects of androgens.

Authors:  W Fried; C W Gurney
Journal:  Ann N Y Acad Sci       Date:  1968-03-29       Impact factor: 5.691
  6 in total
  7 in total

1.  Androgen therapy for anemia in renal failure.

Authors:  S I Ryabov; G D Shostka; T V Vinogradova
Journal:  Int Urol Nephrol       Date:  1980       Impact factor: 2.370

2.  Improvement of anaemia in haemodialysed patients after viral or toxic hepatic cytolysis.

Authors:  P Simon; A Meyrier; T Tanquerel; K S Ang
Journal:  Br Med J       Date:  1980-03-29

Review 3.  Androgens and erythropoiesis: past and present.

Authors:  S Shahani; M Braga-Basaria; M Maggio; S Basaria
Journal:  J Endocrinol Invest       Date:  2009-04-07       Impact factor: 4.256

4.  A case series of the safety and efficacy of testosterone replacement therapy in renal failure and kidney transplant patients.

Authors:  Ahmad Majzoub; Daniel A Shoskes
Journal:  Transl Androl Urol       Date:  2016-12

5.  A randomized trial of adjunct testosterone for cancer-related muscle loss in men and women.

Authors:  Traver J Wright; E Lichar Dillon; William J Durham; Albert Chamberlain; Kathleen M Randolph; Christopher Danesi; Astrid M Horstman; Charles R Gilkison; Maurice Willis; Gwyn Richardson; Sandra S Hatch; Daniel C Jupiter; Susan McCammon; Randall J Urban; Melinda Sheffield-Moore
Journal:  J Cachexia Sarcopenia Muscle       Date:  2018-04-14       Impact factor: 12.910

Review 6.  Testosterone Deficiency as One of the Major Endocrine Disorders in Chronic Kidney Disease.

Authors:  Katarzyna Romejko; Aleksandra Rymarz; Hanna Sadownik; Stanisław Niemczyk
Journal:  Nutrients       Date:  2022-08-21       Impact factor: 6.706

7.  Is Free Testosterone Concentration a Prognostic Factor of Survival in Chronic Renal Failure (CRF)?

Authors:  Stanislaw Niemczyk; Longin Niemczyk; Katarzyna Szamotulska; Zbigniew Bartoszewicz; Katarzyna Romejko-Ciepielewska; Malgorzata Gomółka; Marek Saracyn; Joanna Matuszkiewicz-Rowińska
Journal:  Med Sci Monit       Date:  2015-11-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.